BMPER
BMP-binding endothelial regulator protein
Also known as: BMPER_HUMAN, CRIM3, Cv2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N8U9
- Gene
- BMPER
- Ensembl
- ENSG00000164619
- Chromosome
- 7
- Canonical length
- 685 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
685 residues, UniProt reviewed canonical sequence.
>Q8N8U9|BMPER
1 MLWFSGVGAL AERYCRRSPG ITCCVLLLLN CSGVPMSLAS SFLTGSVAKC ENEGEVLQIP
61 FITDNPCIMC VCLNKEVTCK REKCPVLSRD CALAIKQRGA CCEQCKGCTY EGNTYNSSFK
121 WQSPAEPCVL RQCQEGVVTE SGVRCVVHCK NPLEHLGMCC PTCPGCVFEG VQYQEGEEFQ
181 PEGSKCTKCS CTGGRTQCVR EVCPILSCPQ HLSHIPPGQC CPKCLGQRKV FDLPFGSCLF
241 RSDVYDNGSS FLYDNCTACT CRDSTVVCKR KCSHPGGCDQ GQEGCCEECL LRVPPEDIKV
301 CKFGNKIFQD GEMWSSINCT ICACVKGRTE CRNKQCIPIS SCPQGKILNR KGCCPICTEK
361 PGVCTVFGDP HYNTFDGRTF NFQGTCQYVL TKDCSSPASP FQVLVKNDAR RTRSFSWTKS
421 VELVLGESRV SLQQHLTVRW NGSRIALPCR APHFHIDLDG YLLKVTTKAG LEISWDGDSF
481 VEVMAAPHLK GKLCGLCGNY NGHKRDDLIG GDGNFKFDVD DFAESWRVES NEFCNRPQRK
541 PVPELCQGTV KVKLRAHREC QKLKSWEFQT CHSTVDYATF YRSCVTDMCE CPVHKNCYCE
601 SFLAYTRACQ REGIKVHWEP QQNCAATQCK HGAVYDTCGP GCIKTCDNWN EIGPCNKPCV
661 AGCHCPANLV LHKGRCIKPV LCPQRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BMPER can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 5.2 nTPM
Expression across tissuesHPA
Tissue
- placenta: 5.2 nTPM
- liver: 4.7 nTPM
- cerebellum: 4 nTPM
- lung: 3.8 nTPM
- appendix: 3.7 nTPM
- cerebral cortex: 3.6 nTPM
Single-cell type
- gonadotrophs: 532 nCPM
- fibro-adipogenic progenitors: 497 nCPM
- thyrotrophs: 314 nCPM
- oligodendrocytes: 268 nCPM
- somatotrophs: 211 nCPM
- brain excitatory neurons: 203 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 3.2 nTPM
- cerebral cortex: 3.2 nTPM
- pons: 2.2 nTPM
- basal ganglia: 2 nTPM
- white matter: 2 nTPM
- hippocampal formation: 1.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BMPER.
Disease | AllUniProt
Conditions BMPER is implicated in, by any mechanism.
- Diaphanospondylodysostosis (DSD) MIM:608022
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 436 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Diaphanospondylodysostosis
- BMPER-related disorder
- HP:0003549
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel development
- blood vessel endothelial cell proliferation involved in sprouting angiogenesis
- BMP signaling pathway
- endothelial cell activation
- inner ear development
- negative regulation of BMP signaling pathway
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of SMAD protein signal transduction
- positive regulation of sprouting angiogenesis
- regulation of angiogenesis
- regulation of endothelial cell migration
- regulation of protein localization
- SMAD protein signal transduction
- ureteric bud development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- VWFC domain
- von Willebrand factor, type D domain
- Trypsin Inhibitor-like, cysteine rich domain
- VWF/SSPO/Zonadhesin-like, cysteine-rich domain
- Serine protease inhibitor-like superfamily
- Kielin/Chordin-like & BMP-binding Regulator
- von Willebrand factor type C domain
- von Willebrand factor type D domain
- Trypsin Inhibitor like cysteine rich domain
- C8 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BMPER in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BMPER as an antibody target. Whether an autoantibody or antibody against BMPER could matter depends on whether native BMPER is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BMPER is annotated as secreted, so native BMPER circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label BMPER as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...